ST Pharm Co Ltd
KOSDAQ:237690
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
67 300
117 000
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 116 022.72 KRW. Compared to the current market price of 80 800 KRW, ST Pharm Co Ltd is Undervalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
ST Pharm Co Ltd
Historical valuation for ST Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
|
JP |
D
|
DNA Chip Research Inc
TSE:2397
|
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:

Revenue & Expenses Breakdown
ST Pharm Co Ltd
Balance Sheet Decomposition
ST Pharm Co Ltd
Current Assets | 330.1B |
Cash & Short-Term Investments | 120.9B |
Receivables | 70B |
Other Current Assets | 139.2B |
Non-Current Assets | 391.8B |
Long-Term Investments | 23.4B |
PP&E | 338.7B |
Intangibles | 16.5B |
Other Non-Current Assets | 13.2B |
Current Liabilities | 133.3B |
Accounts Payable | 10.6B |
Accrued Liabilities | 1.6B |
Short-Term Debt | 30B |
Other Current Liabilities | 91B |
Non-Current Liabilities | 85.5B |
Long-Term Debt | 44.8B |
Other Non-Current Liabilities | 40.7B |
Free Cash Flow Analysis
ST Pharm Co Ltd
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
ST Pharm Co Ltd
Revenue
|
274.4B
KRW
|
Cost of Revenue
|
-178B
KRW
|
Gross Profit
|
96.4B
KRW
|
Operating Expenses
|
-69.6B
KRW
|
Operating Income
|
26.8B
KRW
|
Other Expenses
|
2.7B
KRW
|
Net Income
|
29.5B
KRW
|
Profitability Score
Profitability Due Diligence
ST Pharm Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
ST Pharm Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
ST Pharm Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.
Score
ST Pharm Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
ST Pharm Co Ltd
According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 116 025 KRW with a low forecast of 101 000 KRW and a high forecast of 136 500 KRW.
Dividends
Current shareholder yield for ST Pharm Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 116 022.72 KRW.
Compared to the current market price of 80 800 KRW, ST Pharm Co Ltd is Undervalued by 30%.